Veterinary Drug terms — page 15 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Naringetol Naringenin; naringenin; 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 67604-48-2; (+/-)-Naringenin; 4',5,7-Trihydroxyflavanone; 480-41-1; naringetol; Naringenine; salipurpol; (-)-Naringenin; NARIGENIN; Salipurol; (S)-Naringenin; 93602-28-9; MFCD00006844; BE-14348A; NSC 34875; ( inverted exclamation markA)-Naringenin; CHEMBL32571; MLS000028739; MLS000738094; CHEBI:50202; Flavanone, 4',5,7-trihydroxy-; FTVWIRXFELQLPI-UHFFFAOYSA-N; NSC11855; NSC34875; 5,7,4'-Trihydroxyflavanone; AK122638; SMR000059039; 4',7-Trihydroxyflavanone; NSC 11855; Flavanone,5,7-trihydroxy-; Q-100521; EINECS 207-550-2; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-; naringenin-7-sulfate; NSC-34875; Narngenn; CCRIS 8135; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NSC-11855; 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-; ()-Naringenin; 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-; Naringenin (NAR); Prestwick_531; EINECS 266-769-1; Naringenin, 90%; BE 14348A; Opera_ID_106; Prestwick0_000466; Prestwick1_000466; Prestwick2_000466; Prestwick3_000466; Oprea1_194140; SCHEMBL20571; BSPBio_000572; MLS001146907; SPBio_002511; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; BPBio1_000630; MEGxp0_000358; SCHEMBL1934259; ACon1_000582; BDBM19461; CTK7J9188; GTPL10298; DTXSID50274239; (+/-)-Naringenin, >=95%; 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; HMS1569M14; HMS2096M14; HMS2231O18; HMS3352B08; HMS3373N07; HMS3656G15; Naringenin, natural (US), 98%; KS-000001ZW; ZX-AT026530; ANW-43843; BN0800; CN0031; SBB006461; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-; AKOS015895052; (+/-)-Naringenin, analytical standard; CS-W012357; HY-W011641; KS-5142; LS-5089; MCULE-5489217450; (+/-)-Naringenin, ~95% (HPCE); KS-00000R53; SMP1_000060; NCGC00017346-02; NCGC00017346-03; NCGC00017346-04; NCGC00095963-01; NCGC00095963-02; NCGC00095963-03; 4CN-0924; AC-20273; AK106171; K702; LS-39547; SC-18078; ST057236; SY049933; AB1003941; AB1009825; AX8246816; DB-057415; ST2418556; TR-017609; TR-037462; 4CH-012369; FT-0082287; FT-0630981; N0072; M-7677; S00279; 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-one; J-523457; BRD-A94669766-001-02-6; BRD-A94669766-001-04-2; Q57826857; EC19096C-4404-4A16-9BF9-92F9F358E005; ( )-Naringenin; 4?,5,7-Trihydroxyflavanone; H-1-benzopyran-4-one; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, (S)- #; ( inverted exclamation markA)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 4 inverted exclamation marka,5,7-Trihydroxyflavanone; naringenin; 480-41-1; (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; pelargidanon; naringetol; (2S)-Naringenin; salipurpol; Asahi(S)-Naringenin; Naringenine; Salipurol; UNII-HN5425SBF2; CCRIS 5839; C15H12O5; YSO1; (-)-(2S)-Naringenin; CHEMBL9352; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; AI3-23355; HN5425SBF2; CHEBI:17846; (-)-Naringenin; NSC 11855; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2S)-; Flavanone, 4',5,7-trihydroxy- (8CI); (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one; 5,7,4'-Trihydroxyflavanone; NAR; EINECS 207-550-2; SR-01000721771; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NSC-11855; 2uxu; 4deu; pelargidanon 1602; Spectrum_000247; 4eh3; Spectrum2_000325; Spectrum3_000567; Spectrum4_000124; Spectrum5_001423; 4',5,7-triOH-Flavone; 4',5,7-Trihydroxyflavanon; SCHEMBL20570; BSPBio_001954; KBioGR_000508; KBioSS_000727; MLS000574861; BIDD:ER0116; DivK1c_000118; SPECTRUM1500746; SPBio_000329; 4',5, 7-Trihydroxyflavanone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; DTXSID1022392; BDBM23419; CTK8C4789; HMS500F20; KBio1_000118; KBio2_000727; KBio2_003295; KBio2_005863; KBio3_001454; FTVWIRXFELQLPI-ZDUSSCGKSA-N; NINDS_000118; (2S)-5,7,4'-trihydroxyflavone; AIDS001417; HMS2202M06; ZINC156701; (2S)-4',5,7-trihydroxyflavanone; HY-N0100; KS-000010IV; TNP00287; 2580AH; ANW-73132; CCG-38601; LMPK12140001; Phytochemistry 8: 127 (1969); s2394; 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; AKOS016843490; CS-6421; DB03467; FS-4072; RTR-017609; SB17305; SDCCGMLS-0066570.P001; (2S)-4',5,7-trihydroxyflavan-4-one; IDI1_000118; NCGC00016457-01; NCGC00016457-02; NCGC00016457-03; NCGC00017346-01; NCGC00163598-01; CAS-480-41-1; SMR000156272; FT-0617134; FT-0617135; SW219329-1; C00509; Q418374; Q-100666; SR-01000721771-3; SR-01000721771-4; BRD-K08832567-001-02-4; BRD-K08832567-001-06-5; (-)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (S)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 2,3-Dihydro-5,6-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (2S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2S)-; (R)-naringenin; (2R)-naringenin; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; naringenin; R-naringenin; 480-41-1; (S)-Naringenin; 17654-19-2; (+)-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; (+)-naringenin; ZINC1785; SCHEMBL17166263; CHEBI:50201; (2R)-5,7,4'-trihydroxyflavone; HMS3468H18; (2R)-4',5,7-trihydroxyflavanone; ALBB-015405; 4',5,7-Trihydroxyflavanone, 97%; BBL010488; MFCD03265520; STK801623; AKOS004119880; MCULE-5852778653; (2R)-4',5,7-trihydroxyflavan-4-one; SC-85987; VS-02527; BB 0261506; N1370; R6691; ST24036200; (R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; Q27121979; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one; 4H-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-; AI3-23355
Neomycin Framycetin; neomycin; NEOMYCIN B; Soframycin; Actiline; Fradiomycin; Mycifradin; Soframycine; Neomas; Antibiotique; Fradiomycinum; FramicetiFramycetine; Framycetinum; Actilin; Enterfram; Framygen; Myacyne; Neolate; Nivemycin; Caswell No. 595; Vonamycin powder V; Neomcin; Neomin; Fradiomycin B; Neo-Rx; Neomicina [DCIT]; 119-04-0; Framycetinum [INN-Latin]; Neomycine [INN-French]; Neomycinum [INN-Latin]; Framycetine [INN-French]; Framicetina [INN-Spanish]; Framycetin [INN:BAN:DCF]; CCRIS 5462; Fradiomycin sulfate; HSDB 3242; 1404-04-2; UNII-4BOC774388; Framycetin sulfate; EINECS 204-292-2; EINECS 215-766-3; EPA Pesticide Chemical Code 006303; BRN 0101621; Neo-Fradin; CHEBI:7508; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside; Neomycin solution; PGBHMTALBVVCIT-VCIWKGPPSA-N; USAF CB-19; C23H46N6O13; 4BOC774388; Antibiotic produced by Streptomyces decaris. Neomycin B; NeomiciNeomycine; Neomycinum; PIMAVECORT; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-; NMY; Antibiotic 10676; Bycomycin; Jernadex; Framycetin (INN); Neomycin [INN:BAN]; Mycerin; Antibiotic 956; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol; Prestwick3_000158; KDR Kinase Inhibitor, 3; BDBM19; SCHEMBL3279; ANTIBIOTIQUE EF 185; BSPBio_000296; GTPL709; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol; 4-18-00-07476 (Beilstein Handbook Reference); BPBio1_000326; CHEMBL184618; DTXSID2023359; HMS2089P15; C25H50N6O13; ZINC71928291; AKOS024284361; CS-6390; DB00452; NCGC00179612-01; D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy; HY-17624; LS-96091; LS-96095; SC-83646; ST075177; AB00443887; C01737; D05140; 30384-EP2272825A2; 30384-EP2272838A1; 30384-EP2277898A2; 30384-EP2287165A2; 30384-EP2287166A2; 30384-EP2292620A2; 30384-EP2295401A2; 30384-EP2295402A2; 30384-EP2298776A1; 30384-EP2305662A1; 30384-EP2305695A2; 30384-EP2305696A2; 30384-EP2305697A2; 30384-EP2305698A2; 30384-EP2311464A1; AB00443887-03; MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN; J-004060; Q4492348; BRD-K71013094-065-01-2; UNII-I16QD7X297 component PGBHMTALBVVCIT-VCIWKGPPSA-N; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol; (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol; 11004-65-2; 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyc; 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H; lohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H-3,4,5,6-tetrahydropyran-3,4-diol; Caswell No. 595
Neostigmine 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium; 16088-19-0; Norneostigmine; 3-(Dimethylamino)phenyl dimethylcarbamate; Nor Neostigmine; 3-Dimethylaminophenyl dimethylcarbamate; Carbamic acid,dimethyl-, 3-(dimethylamino)phenyl ester (9CI); EINECS 240-240-5; [3-(dimethylamino)phenyl] N,N-dimethylcarbamate; 3-(DIMETHYLAMINO)PHENYL N,N-DIMETHYLCARBAMATE; SCHEMBL2331290; Carbamic acid, dimethyl-, 3-(dimethylamino)phenyl ester; CTK4D0637; DTXSID40167020; FWNHTEHWJKUVPG-UHFFFAOYSA-N; ZINC1997624; 3-dimethylaminophenol dimethylcarbamate; AKOS022181885; VZ35072; 3-(Dimethylamino)phenyl dimethylcarbamate #; (m-Hydroxyphenyl)dimethylamine dimethylcarbamate; 3-Dimethylaminophenyl-N,N-Dimethylaminocarbonate; Dimethylcarbamic acid m-(dimethylamino)phenyl ester; J-009761; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate; 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium; Carbamic acid, N,N-dimethyl-, 3-(dimethylamino)phenyl ester; Neostigmine; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
Netilmicin O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1->6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1->4)-2-deoxy-NI-ethyl-D-streptamine; Netilmicin; 1-N-Aethylsisomicin
Netropsin Netropsin; Sinanomycin; Antibiotic 1142; 1438-30-8; Congocidine; Antibiotic T-1384; Netropsin dihydrochloride; UNII-64B3O0RD7N; 64B3O0RD7N; CHEMBL307767; CH-777-A; NSC 3067; IA 887; BRN 0376913; K-117; 2814-A; T 1384; 1H-Pyrrole-2-carboxamide, 4-((((aminoiminomethyl)amino)acetyl)amino)-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-; F 6; N,4'-Bi(pyrrole-2-carboxamide), N'-(2-carbamoylethyl)-4-((2-guanidinoacetimidoyl)amino)-1,1'-dimethyl-; BDBM17; SCHEMBL197747; CTK8G1803; DTXSID00879834; IDBIFFKSXLYUOT-UHFFFAOYSA-N; C18H26N10O3; ZINC4403891; BDBM50055660; HSCI1_000283; IA-887; LS-44661; NCI60_002614; T-1384; 4-22-00-06712 (Beilstein Handbook Reference); J-007877; Q3874969; 1-amino-3-(4-(4-(2-(amino(iminio)methylamino)acetamido)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamido)propan-1-iminium; 2N-(3-amino-3-iminopropyl)-4-[4-amino(imino)methylaminomethylcarboxamido-1-methyl-1H-2-pyrrolylcarboxamido]-1-methyl-1H-2-pyrrolecarboxamide; 2N-(3-amino-3-iminopropyl)-4-[4-amino(imino)methylaminomethylcarboxamido-1-methyl-1H-2-pyrrolylcarboxamido]-1-methyl-1H-2-pyrrolecarboxamide(netropsin); 4-(2-carbamimidamidoacetamido)-N-{5-[(2-carbamimidoylethyl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}-1-methyl-1H-pyrrole-2-carboxamide; 4-(2-Guanidino-acetylamino)-1-methyl-1H-pyrrole-2-carboxylic acid [5-(2-carbamimidoyl-ethylcarbamoyl)-1-methyl-2,3-dihydro-1H-pyrrol-3-yl]-amide; N-(5-{[(3Z)-3-amino-3-iminopropyl]carbamoyl}-1-methyl-1H-pyrrol-3-yl)-4-[(N-carbamimidoylglycyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; F 6
Nicotinyl alcohol 3-Pyridinemethanol; 3-PYRIDINEMETHANOL; 100-55-0; Nicotinyl alcohol; pyridin-3-ylmethanol; 3-(Hydroxymethyl)pyridine; 3-Pyridylmethanol; Nicotinic alcohol; 3-Pyridylcarbinol; Roniacol; 3-Pyridinylmethanol; Pyridylcarbinol; Pyridine-3-carbinol; Pyridine-3-methanol; beta-Pyridylcarbinol; (Pyridin-3-yl)methanol; 3-Picolyl alcohol; beta-Picolyl alcohol; beta-Pyridinecarbinol; Pyridylmethanol; NU-2121; Ro-1-5155; 3-PYRIDINYLCARBINOL; Pyridyl-3-carbinol; Pyridyl-3-methanol; Niltuvin (free base); .beta.-Pyridylcarbinol; 3-Hydroxymethylpyridine; Pyridin-3-Yl-Methanol; .beta.-Picolyl alcohol; .beta.-Pyridinecarbinol; 3-Pyridyl carbinol; NSC 526046; Nicotinyl alcohol [USAN:BAN]; UNII-9TF312056Y; 3-pyridylmethan-1-ol; EINECS 202-864-6; MFCD00006407; BRN 0107851; RO 1-5155; Nicomethanol Hydrofluoride; MVQVNTPHUGQQHK-UHFFFAOYSA-N; NSC526046; 9TF312056Y; NU 2121; NCGC00159400-05; Pyridine-3-methanol (3-Pyridylcarbinol); DSSTox_CID_3367; DSSTox_RID_76995; DSSTox_GSID_23367; 3-(Hydroxymethyl)pyridine, 98%; Nicotinyltartrate; CAS-100-55-0; SMR000059086; 3-Pyridinemthanol; 3-pyridyl methanol; 3-pyridyl-carbinol; Roniacol (TN); 3-pyridine methanol; pyridine 3-methanol; 3-pyridinyl carbinol; PncA Inhibitor, 4; Ronicol (Salt/Mix); pyridin-3-yl methanol; 3-pyridylmethyl alcohol; PubChem11736; 3-hydroxymethyl pyridine; 3-hydroxymethyl-pyridine; omega-Hydroxy-3-picoline; ACMC-1C7ZK; Nicotinyl alcohol (USAN); (3-Pyridyl)methyl alcohol; 3-Pyridinemethanol, 98%; 3-(hydroxymethyl)-pyridine; SCHEMBL16266; 5-21-02-00172 (Beilstein Handbook Reference); MLS000028906; MLS001424215; SCHEMBL9853210; ZINC1799; CHEMBL1235535; DTXSID6023367; BDBM92860; CHEBI:45213; CTK0H5236; HMS2052G07; HMS2232J07; HMS3372K15; HMS3394G07; BCP20084; HY-B0893; Nicotinyl Alcohol (Pyridylcarbinol); STR00172; Tox21_113448; Tox21_300839; ANW-14316; Ro-15155; SBB004344; AKOS000119474; Tox21_113448_1; 3-Pyridinemethanol, analytical standard; CCG-101090; CS-4356; DB04145; FG-0435; MCULE-4350730997; NC00340; NSC-526046; QC-4379; VZ27242; NCGC00159400-02; NCGC00159400-03; NCGC00159400-04; NCGC00159400-06; NCGC00159400-07; NCGC00257521-01; AC-15599; AK-46173; AM802808; CPD000059086; HC150097; SAM001246894; SC-17825; ST075169; SY001086; SBI-0052904.P002; DB-012725; LS-131670; LS-131710; ST2410844; TC-063624; FT-0083027; P0555; KS-00000814; D05158; M-6218; 28068-EP2272841A1; 28068-EP2301936A1; 28068-EP2314588A1; AB00053787_07; Q411732; 3-Pyridinemethanol, Vetec(TM) reagent grade, 98%; J-650089; W-108954; F0001-0022; InChI=1/C6H7NO/c8-5-6-2-1-3-7-4-6/h1-4,8H,5H; Nicotinyl alcohol; 5-21-02-00172 (Beilstein Handbook Reference)
Niflumic acid 2-[[3-(Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid; Niflumic acid; 5-22-13-00598 (Beilstein Handbook Reference)
Nifuroxazide 4-Hydroxybenzoic acid 2-[(5-nitro-2-furanyl)methylene]hydrazide; Nifuroxazide; R.C. 27-109
Nigericin nigericin; Polyetherin A; Azalomycin M; Helixin C; Antibiotic K 178; Antibiotic X-464; UNII-RRU6GY95IS; RRU6GY95IS; BRN 1696755; 28380-24-7; Epinigericin; CHEBI:7569; X-464; (2R)-2-[(2R,3S,6R)-6-{[(2S,4R,5R,7R,9R,10R)-2-{(2S,2'R,3'S,5R,5'R)-5'-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-2,3'-dimethyloctahydro-2,2'-bifuran-5-yl}-9-methoxy-2,4,10-trimethyl-1,6-dioxaspiro[4.5]dec-7-yl]methyl}-3-methyltetrahydro-2H-pyran-2-yl]propanoic acid; Pandavir; Helix C; NSC292567; C40H68O11; 28643-80-3; BSPBio_001599; SCHEMBL149611; CHEMBL405862; DTXSID9041079; HMS1791P21; HMS1989P21; HMS3402P21; ZINC85552063; DB14056; NCGC00163412-02; LS-96660; HY-127019; CS-0091495; C11609; SR-05000002332; Q7033077; SR-05000002332-2; UNII-VZ2M4595UZ component DANUORFCFTYTSZ-SJSJOXFOSA-N; (2R)-2-((3S)-6-{[2-((5S)-5-{(3S)-5-[(3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethylperhydro-2H-pyran-2-yl]-3-methyloxolan-2-yl}-5-methyloxolan-2-yl)(2S,4R,9R,10R)-9-methoxy-2,4,10-trimethyl-1,6-dioxaspiro[4.5]dec-7-yl]methyl}-3-methylperhydro-2H-pyran-2-yl)propanoic acid; (2R)-2-[(2R,3S,6R)-6-[[(1R,3S,5R,6R,7R,9R)-3-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-tetrahydropyran-2-yl]-3-methyl-tetrahydrofuran-2-yl]-5-methyl-tetrahydrofuran-2-yl]-7-methoxy-1,3,6-trimethyl-4,10-dioxaspiro[4.5]decan-9-yl]methyl]-3-methyl-tetrahydropyran-2-yl]propanoic acid; Nigericin sodium; Nigericin sodium salt; Nigericin (sodium salt); UNII-DGN38HI976; nigericin; Sodium nigericin; Antibiotic K178; DGN38HI976; 28643-80-3; NIGERICIN, MONOSODIUM SALT; NSC 292567; SMR000875327; MLS001336037; MLS001336038; Nigericin, Sodium Salt, Streptomyces hygroscopicus; CHEMBL2165715; AKOS024418750; CCG-208241; CS-5717; Nigericin sodium salt, >=98% (TLC); HY-100381; Q27276393; (2R)-2-[(2R,3S,6R)-6-[[(2S,4R,5R,7R,9R,10R)- 2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-Hydroxy- 6-(hydroxymethyl)-3,5-dimethyl-2-tetrahydropyranyl]-3-methyl- 2-tetrahydrofuranyl]-5-methyl-2-tetrahydrofuranyl]-9-methoxy- 2,4,10-trimethyl-1,6-dioxaspiro[4.5]decan-7-yl]methyl]-3-methyl- 2-tetrahydropyranyl]propanoic acid sodium salt; nigericin; Nigericin sodium; Sodium nigericin; NIGERICIN, MONOSODIUM SALT; NSC 292567; 28643-80-3; SCHEMBL950674; s6653; LS-96662; X-464
Nilutamide 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione; nilutamide; 63612-50-0; Anandron; Nilandron; Nilandrone; 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione; Nilutamida; Nilutamidum; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione; Nilutamidum [Latin]; Nilutamida [Spanish]; RU-23908; Nilutamide [USAN:INN:BAN]; RU 23908; RU 23908-10; 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin; UNII-51G6I8B902; C12H10F3N3O4; BRN 0841906; CHEMBL1274; CHEBI:7573; XWXYUMMDTVBTOU-UHFFFAOYSA-N; 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione; 5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione; 51G6I8B902; NCGC00015754-08; CAS-63612-50-0; 2,4-IMIDAZOLIDINEDIONE, 5,5-DIMETHYL-3-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)-; DSSTox_CID_14165; DSSTox_RID_79118; DSSTox_GSID_34165; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1,3-diazolidine-2,4-dione; Nilandron (TN); SR-01000076034; Nilutamide (USAN/INN); Nilutamide, solid; PubChem19359; Spectrum_001625; Tocris-1759; SpecPlus_000902; Prestwick0_000928; Prestwick1_000928; Prestwick2_000928; Prestwick3_000928; Spectrum2_001973; Spectrum3_001633; Spectrum4_000600; Spectrum5_001512; Lopac-N-8534; N 8534; BIDD:PXR0177; Lopac0_000879; SCHEMBL12670; BSPBio_000836; BSPBio_003325; KBioGR_001100; KBioSS_002105; MLS002154066; BIDD:GT0683; DivK1c_006998; SPECTRUM1504152; SPBio_002125; SPBio_003015; BPBio1_000920; GTPL2864; DTXSID3034165; CTK8B7740; KBio1_001942; KBio2_002105; KBio2_004673; KBio2_007241; KBio3_002545; BCPP000148; HMS1570J18; HMS1922F03; HMS2093A10; HMS2097J18; HMS2230E03; HMS3262P19; HMS3268C18; HMS3369I02; HMS3414N15; HMS3678N13; HMS3714J18; Pharmakon1600-01504152; BCP26617; ZINC3874498; Tox21 110213; Tox21_110213; Tox21_301589; Tox21_500879; ANW-58327; BDBM50135912; CCG-39427; MFCD00864670; NSC758683; s4836; SBB067297; STK633161; 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione; AKOS005565152; AKOS025147305; Tox21_110213_1; AC-5260; BCP9000990; DB00665; LP00879; MCULE-3215206804; NSC-758683; SB19036; SDCCGSBI-0050854.P004; NCGC00015754-01; NCGC00015754-02; NCGC00015754-03; NCGC00015754-04; NCGC00015754-05; NCGC00015754-06; NCGC00015754-07; NCGC00015754-09; NCGC00015754-10; NCGC00015754-11; NCGC00015754-12; NCGC00015754-15; NCGC00015754-16; NCGC00025280-01; NCGC00025280-02; NCGC00025280-03; NCGC00025280-04; NCGC00025280-05; NCGC00025280-06; NCGC00025280-07; NCGC00025280-08; NCGC00255271-01; NCGC00261564-01; 4CA-0906; AK-82300; AS-14123; HY-13702; LS-79181; SC-74493; SMR001233381; ST075550; SBI-0050854.P003; AB0013969; TC-030602; AB00053180; CS-0007719; EU-0100879; FT-0080574; FT-0630740; C08164; D00965; AB00053180_07; 612N500; A834440; L000759; Q3877030; RU-23908; RU 23908; RU23908; SR-01000076034-1; SR-01000076034-3; SR-01000076034-5; SR-01000076034-6; SR-01000076034-9; BRD-K23566484-001-05-2; BRD-K23566484-001-09-4; Z2417927201; Nilutamide, European Pharmacopoeia (EP) Reference Standard; 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione; 1-(3'-trifluoromethyl-4'-nitrophenyl)4,4-dimethyl-imidazoline-2,5-dione; 1-(3'-trifluoromethyl-4'nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione; 1-(3'trifluoromethyl-4'-nitropheyl)-4,4-dimethyl-imidazoline-2,5-dione; 1-(3-'trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione; 1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl imidazolidine-2,5-dione; 1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazolidine-2,5-dione; 1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazoline-2,5-dione; 1-(3-trifluoromethyl-4-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione; 3-(3-(trifluoromethyl)-4-nitrophenyl)-5,5-dimethylimidazolidine-2,4-dione; 2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-; 5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)-phenyl)imidazolidine-2,4-dione; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-imidazolidine-2,4-dione; Nilutamide; 5-24-05-00358 (Beilstein Handbook Reference)
Nilvadipine 2-Cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylic acid 3-methyl-5-(1-methylethyl)ester; Nilvadipine; BRN 3572609
Nimesulide N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide; nimesulide; 51803-78-2; N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide; Mesulid; Aulin; Flogovital; Sulidene; Nimed; 4-NITRO-2-PHENOXYMETHANESULFONANILIDE; R-805; Nisulid; Nimesulidum [INN-Latin]; Nimesulida [INN-Spanish]; R 805; UNII-V4TKW1454M; 4-Nitro-2-phenoxy-methanesulfonanilide; 4'-Nitro-2'-phenoxymethanesulfonanilide; Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-; EINECS 257-431-4; 4'-Nitro-2'-phenoxymethansulfonanilid; BRN 2421175; CHEMBL56367; MLS000069680; V4TKW1454M; Methanesulfonanilide, 4'-nitro-2'-phenoxy-; CHEBI:44445; HYWYRSMBCFDLJT-UHFFFAOYSA-N; NCGC00015725-02; SMR000058484; CAS-51803-78-2; DSSTox_CID_17250; DSSTox_RID_79316; DSSTox_GSID_37250; W-105866; C13H12N2O5S; Antifloxil; Nimesulida; Nimesulidum; Guaxan; NIM; Nimesulide [BAN:INN]; Nimesulide [INN:BAN]; SR-01000000218; Aldoron; Nimedex; Orthobid; CCRIS 8225; Nise Gel; Nimesulide,(S); Prestwick_618; Spectrum_001577; Nimesulide (JAN/INN); Opera_ID_1247; Prestwick0_000194; Prestwick1_000194; Prestwick2_000194; Prestwick3_000194; Spectrum2_001541; Spectrum3_001576; Spectrum4_000178; Spectrum5_000964; Lopac-N-1016; N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide; Lopac0_000855; SCHEMBL24882; BSPBio_000147; BSPBio_001103; BSPBio_003112; KBioGR_000443; KBioGR_000695; KBioSS_000443; KBioSS_002057; MLS001148268; DivK1c_000693; SPECTRUM1503231; SPBio_001382; SPBio_002068; N-(4-nitro-2-phenoxyphenyl); BPBio1_000163; GTPL7401; NIM-03; DTXSID3037250; BCBcMAP01_000034; HMS502C15; KBio1_000693; KBio2_000443; KBio2_002057; KBio2_003011; KBio2_004625; KBio2_005579; KBio2_007193; KBio3_000825; KBio3_000826; KBio3_002612; NINDS_000693; Bio2_000382; Bio2_000862; HMS1362G05; HMS1568H09; HMS1792G05; HMS1922K17; HMS1990G05; HMS2089B14; HMS2095H09; HMS2234K19; HMS3262L11; HMS3269G17; HMS3371J19; HMS3403G05; HMS3414P09; HMS3649A04; HMS3655D13; HMS3678P07; HMS3712H09; Pharmakon1600-01503231; BCP10076; HY-B0363; ZINC4617749; Tox21_110207; Tox21_301850; Tox21_500855; BDBM50056999; CCG-39319; CN0038; EI-287; MFCD00079470; NSC758412; s2040; STL018679; AKOS015897356; Tox21_110207_1; AC-4524; CS-2420; DB04743; KS-1277; LP00855; MCULE-4217888990; NSC-758412; SDCCGSBI-0050831.P004; IDI1_000693; IDI1_002137; NCGC00015725-01; NCGC00015725-03; NCGC00015725-04; NCGC00015725-05; NCGC00015725-06; NCGC00015725-07; NCGC00015725-08; NCGC00015725-09; NCGC00015725-10; NCGC00015725-11; NCGC00015725-12; NCGC00015725-13; NCGC00015725-15; NCGC00015725-16; NCGC00021842-03; NCGC00021842-04; NCGC00021842-05; NCGC00021842-06; NCGC00021842-07; NCGC00021842-08; NCGC00255661-01; NCGC00261540-01; AK163559; LS-90290; SC-17925; SBI-0050831.P003; AB2000444; DB-052029; AB00052332; EU-0100855; FT-0630650; N0984; ST51015069; SW196785-3; (methylsulfonyl)(4-nitro-2-phenoxyphenyl)amine; D01049; N 1016; Q20994; AB00052332-16; AB00052332_17; AB00052332_18; n-(4-nitro-2-phenoxy-phenyl)-methanesulfonamide; N-[4-nitro-2-(phenoxy)phenyl]methanesulfonamide; 803N782; A828786; SR-01000000218-2; SR-01000000218-6; SR-01000000218-7; BRD-K76775527-001-06-2; BRD-K76775527-001-18-7; SR-01000000218-11; Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)- (9CI); Nimesulide, European Pharmacopoeia (EP) Reference Standard; Nimesulide, Pharmaceutical Secondary Standard; Certified Reference Material; Nimesulide for peak identification, European Pharmacopoeia (EP) Reference Standard; Nimesulide; R-805
Nimodipine 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; Nimodipine; BAY e 9736
Nitrapyrin 2-Chloro-6-(trichloromethyl)pyridine; NITRAPYRIN; 2-Chloro-6-(trichloromethyl)pyridine; 1929-82-4; N-Serve; Pyridine, 2-chloro-6-(trichloromethyl)-; Dowco-163; N-Serve nitrogen stabilizer; 2-chloro-6-trichloromethylpyridine; Caswell No. 217; Nitrapyrine [ISO-French]; UNII-8PCE86U01W; Nitrapyrin [ANSI:BSI:ISO]; CCRIS 4599; 2-Chloro-6-trichloromethyl pyridine; EINECS 217-682-2; EPA Pesticide Chemical Code 069203; BRN 1618997; 8PCE86U01W; 2-CHLORO-6-(TRICHLOROMETHYL) PYRIDINE; CHEBI:81935; DCUJJWWUNKIJPH-UHFFFAOYSA-N; MFCD00072500; DSSTox_CID_4216; DSSTox_RID_77330; DSSTox_GSID_24216; Nitrapyrine; 6-chloro-2-(trichloromethyl)pyridine; CAS-1929-82-4; alpha,alpha,alpha,6-tetrachloro-2-picoline; ACMC-1AP8Q; EC 217-682-2; SCHEMBL41442; 5-20-05-00500 (Beilstein Handbook Reference); KSC924E3B; MLS002152872; CHEMBL1557091; DTXSID0024216; CTK8C4230; 2-chloro-6-trichloromethylpyridin; ZINC139440; 2-chloro-6(trichloromethyl)pyridine; 6-chloro-2-trichloromethyl pyridine; KS-000001QW; Tox21_202036; Tox21_300916; ANW-71320; LS-968; SBB038064; STK843145; 2 -chloro-6-(trichloromethyl)pyridine; AKOS000267961; AM84664; CS-W019363; MCULE-1915209467; RTR-008961; NCGC00091152-01; NCGC00091152-02; NCGC00091152-03; NCGC00091152-04; NCGC00091152-05; NCGC00254819-01; NCGC00259585-01; AC-23339; AK-98722; AS-15459; P464; SC-74903; SMR000777845; TR-008961; A4252; FT-0633921; ST24027935; ST50036731; EN300-93027; Nitrapyrin, PESTANAL(R), analytical standard; 2-Chloro-6-(trichloromethyl)pyridine, >=98%; 29N824; C-5071; C18751; 135739-EP2275422A1; 135739-EP2292608A1; Q-101453; Q1993935; 2-Picoline, .alpha.,.alpha.,.alpha.,6-tetrachloro-; 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one; 2-Chloro-6-(trichloromethyl)pyridine, analytical reference material; Nitrapyrin; 5-20-05-00500 (Beilstein Handbook Reference)
Nitrazepam 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; nitrazepam; 146-22-5; Benzalin; Neozepam; Imeson; Mogadon; Remnos; Neuchlonic; Apodorm; Calsmin; Eunoctin; Imesont; Nitrados; Radedorm; Sonebon; Trazenin; Hipnax; Hipsal; Nelmat; Surem; Epibenzalin; Epinelbon; Nitrenpax; Somitran; Sonnolin; Unisomnia; Cerson; Dumolid; Nelbon; Paxisyn; Pelson; Relact; N-Desmethylnimetazepam; Persopit; Gerson; Ibrovek; Eatan; Dormo-Puren; Dormin-5; Mitidin; Eatan N; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Nitrazepamum; Mogadone; Magadon; Megadon; Mogadan; Nitrazepamum [INN-Latin]; Ro 4-5360; 7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; LA 1; Ro 5-3059; NSC-58775; LA 1 (VAN); Dormicum (anticonvulsant); 7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one; 7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one; S 2000; Nitrazepam [USAN:INN:BAN:JAN]; UNII-9CLV70W7HS; 2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on; 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; CCRIS 1931; 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-; EINECS 205-665-2; NSC 58775; BRN 0757185; 9CLV70W7HS; CHEMBL13209; CHEBI:7581; DEA No. 2834; Nitrodiazepam; Somnite; KJONHKAYOJNZEC-UHFFFAOYSA-N; C15H11N3O3; NSC58775; NCGC00159358-02; 2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one; Calsamin; Eunoktin; Ipersed; Nitravet; Nitrempax; Noctesed; Pacisyn; Somnased; Somnibel; DSSTox_CID_3372; DSSTox_RID_77000; DSSTox_GSID_23372; Nitrazepam (TN); Benzalin (TN); CAS-146-22-5; SMR000058302; ISOPROPYLACETATE/NITRAZEPAM; Ro 53-60; ChemDiv1_022312; Oprea1_476234; SCHEMBL35202; 5-24-04-00344 (Beilstein Handbook Reference); MLS001304053; MLS001424061; DTXSID5023372; Nitrazepam (JP17/USAN/INN); CTK0H5746; HMS650G04; KJONHKAYOJNZEC-UHFFFAOYSA-; N05CD02; 1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; HMS2051F19; HMS2272G03; HMS3393F19; 7-Nitro-1,4-benzodiazepin-2-one; NITRAZEPAM METHANOL SOLUTION; ZINC4311748; Tox21_111601; BDBM50020856; PDSP1_000120; PDSP2_000120; Ro-45360; Ro-53059; STK806322; AKOS002254707; Nitrazepam 0.1 mg/ml in Acetonitrile; Nitrazepam 1.0 mg/ml in Acetonitrile; Tox21_111601_1; WLN: T67 GMV JN IHJ CNW KR; AB02342; AC-4537; CCG-100977; DB01595; MCULE-3394241963; NC00227; NCGC00159358-03; CC-32888; CPD000058302; LS-34311; SAM001246711; 2H-1, 1,3-dihydro-7-nitro-5-phenyl-; 7-Nitro-5-phenyl-2,4-benzodiazepin-2-one; DB-042832; RO-4-5360; RO-5-3059; FT-0602365; C07487; D00531; 146N225; A808471; C-17711; Q410078; 7-nitro-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one; Nitrazepam, British Pharmacopoeia (BP) Reference Standard; Nitrazepam, European Pharmacopoeia (EP) Reference Standard; (Z)-7-nitro-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one; 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #; 7-Nitro-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one; InChI=1/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19); Nitrazepam solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Nitrazepam; S 2000
Nitrilotriacetic acid 4-04-00-02441 (Beilstein Handbook Reference)
Nitrofurans Nitrofuran Derivatives; Furaltadone; Furazolidone; Furazidin; Nifurtoinol; Nitrofural; Nitrofurantoin
Nitrofurantoin 1-[[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione; nitrofurantoin; 67-20-9; Macrodantin; 5-Nitrofurantoin; Furadantin; Furadonine; Furadantine; Furadantoin; Furadoine; Furadontin; Furantoin; Nifurantin; Nitrofuradantin; Nitrofurantoine; Berkfurin; Chemiofuran; Furachel; Furadonin; Furatoin; Furobactina; Macrobid; Novofuran; Orafuran; Parfuran; Trantoin; Urantoin; Urofurin; Welfurin; Zoofurin; Cyantin; Cystit; Furalan; Furina; Ituran; Nitoin; Urizept; Urodin; Urolong; Furadantine mc; Uro-Tablinen; Fur-ren; Furadoninum; Macrofuran; Nitrofurantoina; Benkfuran; Dantafur; Furaloid; Nierofu; Macpac; Nitrex; Nitrofurantoinum; Fua Med; N-Toin; Macrodantina; Berkfuran; Cistofuran; Gerofuran; Macrofurin; Nifuretten; Phenurin; Siraliden; Uerineks; Urofuran; Alfuran; Ceduran; Furabid; Furedan; PiyEloseptyl; Urolisa; Usaf ea-2; Furadantina MC; Furadantine-MC; Furophen T; Nitrofur-C; Ro-Antoin; Furadantin Retard; Uro-Selz; 1-(5-Nitro-2-furfurylideneamino)hydantoin; N-(5-Nitrofurfurylidene)-1-aminohydantoin; N-(5-Nitro-2-furfurylidene)-1-aminohydantoin; 1-((5-Nitrofurfurylidene)amino)hydantoin; 1-[(5-Nitrofurfurylidene)amino]hydantoin; 1-(5-Nitro-2-furfurylidenamino)hydantoin; Nitrofurantoina [DCIT]; NITROFURANTOIN, MACROCRYSTALLINE; Nitrofurantoine [INN-French]; Nitrofurantoinum [INN-Latin]; NCI-C55196; NSC 2107; NITROFURANTOIN MACROCRYSTALLINE; NSC 44150; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina; CCRIS 1192; UNII-927AH8112L; HSDB 3135; EINECS 200-646-5; 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina [Polish]; AI3-26388; MLS000028500; CHEBI:71415; Hydantoin, 1-((5-nitrofurfurylidene)amino)-; 1-[[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione; 2,4-Imidazolidinedione, 1-(((5-nitro-2-furanyl)methylene)amino)-; 2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]-; NSC-2107; Ivadantin; MFCD00003224; C8H6N4O5; 927AH8112L; SMR000058271; 1-(((5-Nitrofuran-2-yl)methylene)amino)imidazolidine-2,4-dione; 1-{[(1E)-(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione; furophen; urodil; Furodantin; Fuamed; uro-tablineu; 1-(((5-nitro-2-furanyl)methylene)amino)-2,4-imidazolidinedione; 1-(((5-Nitrofuran-2-yl)methylene)-amino)imidazolidine-2,4-dione; fua-med; 1-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione; 2,4-Imidazolidenedione, 1-(((5-nitro-2-furanyl)methylene)amino)-; Nitrofurantoin, 98%; Furadantin (TN); NITROFURANTION; Hydantoin, 1-[(5-nitrofurfurylidene)amino]-; SR-05000001681; Nitrofurantoin [USAN:INN:BAN:JAN]; NSC2107; Furantoina; Furadoin; Furadoxyl; Uvamin; NSC44150; 1-[[(5-nitrofuran-2-yl)methylene]amino]imidazolidine-2,4-dione; NSC-44150; Nitrofurantoin (JAN/USP/INN); Furophen T-Caps; NCGC00091505-01; NCGC00091505-07; Prestwick_358; Nitrofurantoin Macro; 5-Nitrofurantoindorn; J01XE01; Nitrofurantoin [USP:INN:BAN:JAN]; PubChem6954; ND-3320; ND-7248; Nitrofurantoin, 97%; Nitrofurantoin anhydrous; 1-[(5-:nitrofurfurylidene)amino]hydantoin; Prestwick2_000168; Prestwick3_000168; Spectrum5_001367; Nitrofurantoin macrocrystal; Nitrofurantoin, crystalline; CHEMBL572; Nitrofurantoin Macrocrystals; cid_4509; N-(5-nitro-2-furfurylidene)-1-aminohyda ntoin; Nitrofurantoin, macrocrystals; SCHEMBL29470; SCHEMBL29472; BSPBio_000035; BSPBio_002073; 1-{[(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione; ARONIS27199; BIDD:GT0181; SPECTRUM1500433; 1-{[(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione; BPBio1_000039; BDBM57045; CHEBI:95222; HMS500L06; NXFQHRVNIOXGAQ-YCRREMRBSA-N; HMS1568B17; HMS1920P21; HMS2091H16; HMS2095B17; HMS3712B17; Pharmakon1600-01500433; 1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione; HY-A0090; ZINC7997568; 1-{[(1E)-(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione; CCG-40108; NSC757243; s4536; SBB056985; STK009471; STL454163; AKOS001678301; DB00698; LS-1560; NSC-757243; RTR-022602; IDI1_000224; NCGC00091505-03; NCGC00091505-04; NCGC00091505-05; NCGC00091505-06; NCGC00091505-08; NCGC00091505-09; NCGC00091505-10; CPD000058271; SAM002554913; SC-06194; 1-((5-nitrofurfurylidene)amino)-hydantoin; SBI-0051457.P003; TR-022602; AB00513815; N0883; ST24031483; A16008; C07268; D00439; J10193; Z-1941; AB00052052_03; A835659; Hydantoin, n-(5-nitro-2-furfurylidene)-1-amino-; Nitrofurantoin, VETRANAL(TM), analytical standard; Q-201479; SR-05000001681-1; SR-05000001681-2; SR-05000001681-3; SR-05000001681-4; BRD-K76927775-001-05-0; Nitrofurantoin, Antibiotic for Culture Media Use Only; Hydantoin, 1-[(5-nitrofurfurylidene)amino]- (7CI,8CI); 1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione; (E)-1-[(5-nitro-2-furyl)methylideneamino]imidazolidine-2,4-dione; 1-([(5-Nitro-2-furyl)methylidene]amino)-2,4-imidazolidinedione #; 1-[(E)-(5-nitro-2-furanyl)methylideneamino]imidazolidine-2,4-dione; Nitrofurantoin, United States Pharmacopeia (USP) Reference Standard; (E)-1-(((5-Nitrofuran-2-yl)methylene)amino)imidazolidine-2,4-dione; 1-[(1E)-2-(5-nitro(2-furyl))-1-azavinyl]-1,3-diazolidine-2,4-dione; 1-{[(E)-1-(5-nitro-2-furyl)methylidene]amino}-1H-imidazole-2,4(3H,5H)-dione; 4-hydroxy-1-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}-1,5-dihydro-2H-imidazol-2-one; N-(5-Nitro-2-furfurylidine)-1-aminohydantoin; N-(5-Nitrofurfurylidene)-1aminohydantoin; Nitrofurantoin, Pharmaceutical Secondary Standard; Certified Reference Material; 178170-37-1; Nitrofurantoin; AI3-26388
Nitrofurazone 2-((5-Nitro-2-furanyl)methylene)hydrazine carboxamide; Nitrofurazone; U-6421
Nitroglycerin 1,2,3-Propanetriol, 1,2,3-Trinitrate; Nitroglycerin; 4-01-00-02762 (Beilstein Handbook Reference)
Nitroimidazoles Metronidazole; Ornidazole; Secnidazole; Tinidazole
Nitromersol [2-Methyl-5-nitrophenolato(2-)-kappaC6,kappaO1]mercury; Nitromersol; EINECS 205-112-5
Nitroxoline 5-Nitro-8-quinolinol; NITROXOLINE; 5-nitroquinolin-8-ol; 4008-48-4; 8-Hydroxy-5-nitroquinoline; 5-Nitro-8-hydroxyquinoline; 5-Nitro-8-quinolinol; Nitroxolin; 5-Nitrox; Noxibiol; 8-Quinolinol, 5-nitro-; 5-Nitroxine; 5-Nitroks; 5-NOK; Nibiol; Noxin; 5-Nitro-8-oxyquinoline; 5NOK; Nitroxolinum; 5-Nitro-8-oxychinoline; NitroxoliGalinok; Isinok; Nicene Forte; Nitroxolinum [INN-Latin]; Nitroxolina [INN-Spanish]; Uro-Coli; A-82; BAS 58; NSC 74947; Nitroxoline [INN:BAN:DCF]; MLS000069750; UNII-A8M33244M6; EINECS 223-662-4; BRN 0166146; SMR000059036; CHEBI:67121; RJIWZDNTCBHXAL-UHFFFAOYSA-N; MFCD00006791; A8M33244M6; NCGC00160664-01; DSSTox_CID_26284; DSSTox_RID_81510; DSSTox_GSID_46284; Notroxoline; CAS-4008-48-4; Nitroxoline (TN); HNQ; Nitrohydroxyquinoline; Nitroxoline (INN); PubChem7565; 3ai8; 5-Nitroquinoline-8-ol; ACMC-209jar; Opera_ID_204; 5-Nitro-quinolin-8-ol; 5-Nitro-8hydroxyquinoline; Quinolin-8-ol, 5-nitro-; Oprea1_594857; 8-Hydroxy-5-nitro-chinoline; 5-21-03-00297 (Beilstein Handbook Reference); cid_19910; MLS001148594; SCHEMBL151248; REGID_for_CID_19910; 5-Nitroquinolin-8-ol, 96%; WLN: T66 BNJ GNW JQ; CHEMBL1454910; DTXSID4046284; BDBM64987; CTK1D5867; HMS2230I14; HMS3264C05; HMS3374D08; KUC105356N; Pharmakon1600-01506173; 8-Hydroxy-5-nitroquinoline, 96%; HY-B1159; NSC74947; Tox21_111969; ANW-29281; BBL023366; KSC-8-140; NSC-74947; NSC760393; s4591; SBB037944; STK099582; ZINC15831592; AKOS001053242; Tox21_111969_1; AC-7828; CCG-213981; CS-4761; DB01422; LS20671; MCULE-8622459990; NSC-760393; PS-5547; RTR-015997; VQ10269; NCGC00160664-03; SC-04243; ST086486; AB0010831; AB1003427; DB-049530; LS-142569; TR-015997; A6696; FT-0621541; ST24029546; T7793; 08N484; D07245; 5-Nitro-8-quinolinol|5-Nitro-8-hydroxyquinoline; AB00572598_14; AG-205/04556035; Q304570; SR-01000721863; SR-01000721863-4; W-106391; Z56922155; InChI=1/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12; Nitroxoline; A-82
Nocodazole [5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester; Nocodazole; R 17,934
Nonyl alcohol 1-Nonanol; 1-Nonanol; Nonan-1-ol; Nonanol; 143-08-8; NONYL ALCOHOL; n-Nonyl alcohol; Pelargonic alcohol; Octyl carbinol; 1-Hydroxynonane; Nonalol; n-Nonanol; n-Nonan-1-ol; Alcohol C-9; C9 alcohol; Alcohol C9; Fatty alcohol(C9); Nonylalkohol; Pelargonalkohol; UNII-NGK73Q6XMC; NSC 5521; FEMA No. 2789; HSDB 5145; EINECS 205-583-7; MFCD00002990; NGK73Q6XMC; BRN 0969213; AI3-03962; 28473-21-4; CHEBI:35986; ZWRUINPWMLAQRD-UHFFFAOYSA-N; 1-Nonanol, 97%; nonanols; EINECS 249-048-6; Nonanol-(1); Nonyl alcohol, 8CI; ACMC-209cpi; 1-Nonanol, 98%; DSSTox_CID_2008; EC 205-583-7; DSSTox_RID_76457; DSSTox_GSID_22008; SCHEMBL19807; WLN: Q9; 4-01-00-01798 (Beilstein Handbook Reference); KSC175S7J; BIDD:ER0370; CHEMBL24563; Pelargonic alcohol (1-nonanol); DTXSID6022008; Nonyl alcohol, >=98%, FCC; BDBM22607; CTK0H5974; FEMA 2789; KS-00000WCZ; Nonyl alcohol, Pelargonic alcohol; NSC5521; NSC-5521; ZINC1686993; Tox21_300869; 8145AF; ANW-20740; LMFA05000092; SBB059907; STL283956; AKOS009031412; DB03143; LS-2991; MCULE-4020281400; RTR-005495; TRA0009434; 1-Nonanol, purum, >=98.0% (GC); NCGC00248194-01; NCGC00254773-01; CAS-143-08-8; TR-005495; FT-0608164; N0292; ST51046174; C14696; 81307-EP2272817A1; 81307-EP2305687A1; 81307-EP2380568A1; 89678-EP2305033A1; 89678-EP2377844A2; 218917-EP2377844A2; A808013; Q161662; J-007741; F0001-0508; 2E051A08-F94E-40C2-88CA-7030E15C76BF; InChI=1/C9H20O/c1-2-3-4-5-6-7-8-9-10/h10H,2-9H2,1H; C9 alcohol
Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; Norepinephrine; noradrenaline; L-Noradrenaline; Arterenol; Levarterenol; 51-41-2; Levophed; (-)-Norepinephrine; L-Norepinephrine; (R)-Noradrenaline; (R)-Norepinephrine; L-arterenol; (-)-Arterenol; Levonor; (-)-NORADRENALINE; Levonorepinephrine; Adrenor; Aktamin; Levonoradrenaline; Sympathin E; (R)-(-)-Norepinephrine; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; Noradrenalin; Norepirenamine; norepinephrinum; Levoarterenol; Noradrenalinum; Norartrinal; Nor-Epirenan; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; L-3,4-dihydroxyphenylethanolamine; Levarterenolo [DCIT]; D-(-)-Noradrenaline; Noradrenalina [Italian]; Noradrenalin, l-; l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; (-)-(R)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; Noreinefrina [INN-Spanish]; Nor adrenalin (TN); Norepinephrinum [INN-Latin]; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-; UNII-X4W3ENH1CV; Noradrenalina; NOREPINEPHIRINE; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-; EINECS 200-096-6; X4W3ENH1CV; BRN 4231961; CHEMBL1437; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-; CHEBI:18357; SFLSHLFXELFNJZ-QMMMGPOBSA-N; 138-65-8; (R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol; Levarterenolo; Noreinefrina; 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; 1,2-Benzenediol,4-(2-amino-1-hydroxyethyl)-; W-105896; d-Arterenol; 1,2-Benzenediol, 4-((R)-2-amino-1-hydroxyethyl)-; d-Norepinephrine; xi-Norepinephrine; norepinefrina; Ecteinascidins; Nor adrenalin; (+)-Noradrenaline; Norepinephrine [INN:JAN]; Norepinephrine (INN); Noradrenaline (JP15); Norepinephrine l-Tartrate (1:1); (-)-Arterenol free base; Norepinephrine Noradrenalin; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-; Nor-adrenaline; R-norepinephrine; DermX; MFCD00025592; Norepinephrine [INN:BAN:JAN]; HSDB 7772; Adrenaline Impurity; ALBB-006229; (?)-Norepinephrine; PubChem6074; Spectrum_001009; Noradrenaline (JP17); Spectrum2_001064; Spectrum3_000520; Spectrum4_000078; Spectrum5_001068; DSSTox_CID_3378; bmse000404; SCHEMBL2609; DSSTox_RID_77004; DSSTox_GSID_23378; BSPBio_002079; GTPL505; KBioGR_000635; KBioSS_001489; MLS006010883; DivK1c_000230; SPECTRUM1500436; SPBio_001048; Levarterenol; Levophed; Arterenol; 4-[(1R)-2-amino-1-hydroxy-ethyl]benzene-1,2-diol; SGCUT00123; DTXSID5023378; CTK4C1344; HMS500L12; KBio1_000230; KBio2_001489; KBio2_004057; KBio2_006625; KBio3_001579; ZINC57624; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; NINDS_000230; HMS1920B08; HMS2089E18; HMS2091J08; Pharmakon1600-01500436; to_000024; Tox21_301944; ANW-74377; BDBM50029051; CCG-40104; FCH920095; NSC757246; PDSP1_001111; PDSP2_001095; s9507; STK503776; AKOS006345192; AKOS015854572; API0003193; DB00368; NSC-757246; SDCCGSBI-0050082.P004; CAS-51-41-2; IDI1_000230; NCGC00159406-03; NCGC00159406-04; NCGC00159406-05; NCGC00159406-06; NCGC00159406-07; NCGC00159406-08; NCGC00159406-09; NCGC00159406-10; NCGC00159406-11; NCGC00255328-01; AS-56654; CC-33071; HY-13715; LS-42676; SC-04955; SMR000058585; (-)-Norepinephrine, >=98%, crystalline; (R)-4-(2-Amino-1-hydroxyethyl)catechol; SBI-0050082.P003; TR-005105; CS-0007744; FT-0603221; FT-0658803; FT-0679201; 4786-EP2270011A1; 4786-EP2280010A2; 4786-EP2284171A1; 4786-EP2287163A1; 4786-EP2287165A2; 4786-EP2287166A2; 4786-EP2292620A2; 4786-EP2298776A1; 4786-EP2305644A1; 4786-EP2305648A1; 4786-EP2305677A1; 4786-EP2305678A1; 4786-EP2308864A1; 4786-EP2308873A1; 4786-EP2308875A1; 4786-EP2311831A1; 4786-EP2314571A2; 4786-EP2316836A1; C-4015; C00547; D00076; 21779-EP2269990A1; 21779-EP2272847A1; 21779-EP2284170A1; 21779-EP2287165A2; 21779-EP2287166A2; 21779-EP2292620A2; 21779-EP2298731A1; 21779-EP2298742A1; 21779-EP2305669A1; 21779-EP2311828A1; 21779-EP2311835A1; 21779-EP2314571A2; 21779-EP2377510A1; AB00052424-06; AB00052424_07; AB00052424_08; 025N592; C-05156; Q186242; UNII-K294OAI79V component SFLSHLFXELFNJZ-QMMMGPOBSA-N; (-)-NORADRENALINE/ 1,?2-?Benzenediol, 4-?[(1R)?-?2; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI); 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(-)-; Benzyl alcohol, .alpha.-(aminomethyl)-3,4-dihydroxy-, (+)-; (-)-NORADRENALINE/ 1,?2-?Benzenediol, 4-?[(1R)?-?2-?amino-?1-?hydroxyethyl]?-; Norepinephrine; Aktamin
Norethindrone (17alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one; norethindrone; Norethisterone; 68-22-4; Micronor; 19-Norethisterone; Norethisteron; Norcolut; Noriday; Norlutin; Primolut-N; Norethynodrone; Conludag; Micronovum; Norluten; Camila; Utovlan; Mini-pill; Mini-Pe; Noresthisterone; Conludaf; Micronett; Noralutin; Norethyndron; Norgestin; Norluton; Proluteasi; Anovule; Gestest; Norfor; Utovlar; Norpregneninlone; 19-Nor-ethindrone; Norpregneninolone; Nor-QD; Ethinylnortestosterone; Anovulatorio; Ciclovulan; Norethadrone; Norethisteronum; Norethynodron; Noretisterona; Estrinor; Gencept; Microneth; Norethin; Synphase; Triella; Genora; Milli; Nelova; Nodiol; Orlest; Noraethisteronum; 17alpha-Ethynyl-19-nortestosterone; Norpregneninotone; Ethynylnortestosterone; Norcept-E; 19-Nor-17alpha-ethynyltestosterone; Synphasic 28; Brevinor 21; Brevinor 28; Trinovum 21; Noriday 28; Ethynylmortestosterone; Jenest-28; 17alpha-Ethinyl-19-nortestosterone; Brevinor-1 21; Brevinor-1 28; Tri-Norinyl; Anhydrohydroxynorprogesterone; Ovysmen 1 35; Noretisterone [DCIT]; Ortho-Novum 1 35; Ortho-Novum 1 50; Minovlar; Nor-Q.D.; Ortho-Novum 7 7 7; Ovysmen 0.5 35; Ortho 1 35; 19-Norethinyltestosterone; Ortho 7 7 7; Ethinyl-19-nortestosterone; Normapause; Menzol; Norethisteronum [INN-Latin]; Noretisterona [INN-Spanish]; 17alpha-Ethynyl-4-estren-17-ol-3-one; 17-alpha-Ethynyl-19-nortestosterone; 19-Nor-17-alpha-ethynyltestosterone; 19-Nor-17-ethinyltestosterone; 17alpha-Ethinylestra-4-en-17beta-ol-3-one; Nora-BE; Norethisterone [Progestins]; 17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one; 17-alpha-Ethynyl-4-estren-17-ol-3-one; 19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one; 17alpha-Ethynyl-17-hydroxy-4-estren-3-one; Activella; 17-Ethinyl-19-nortestosterone; 19-nor-17alpha-Ethynylandrosten-17beta-ol-3-one; 19-Nor-17alpa-ethynyltestosterone; 4-Estren-17alpha-ethynyl-17beta-ol-3-one; NSC-9564; 17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one; 17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one; 17-alpha-Ethynyl-17-hydroxy-4-estren-3-one; CCRIS 484; norethisterone (norethindrone); 17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one; UNII-T18F433X4S; SC 4640; 17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one; Norethindrone (USP); Norethindrone [USP]; Primolut N; 19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one; 19-Nor-17-ethinyl testosterone; HSDB 3370; 19-Norethindrone; 17-ethynyl-17beta-hydroxyestr-4-en-3-one; 19-Nortestosterone, 17-ethynyl-; 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one; 17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one; 19-Nor-ethinyl--4,5-testosterone; EINECS 200-681-6; 19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one; BRN 1915671; CHEMBL1162; Combipatch; 17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one; Norethindrone (Norethisterone); AI3-26422; (17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one; CHEBI:7627; (8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one; Conceplan; 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-; Errin; 17-alpha-Ethinylestra-4-en-17-beta-ol-3-one; Estr-4-en-3-one, 17alpha-ethynyl-17-hydroxy-; T18F433X4S; 17-alpha-19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-; 17alpha-Ethinyl-17beta-hydroxy-delta(sup:4)-estren-3-one; 19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-; Noretisterone; 17-alpha-Ethinyl-17-beta-hydroxy-delta(sup:4)-estren-3-one; 17-alpha-Ethynyl-17-beta-hydroxy-19-norandrost-4-en-3-one; Norcolute; DSSTox_CID_3380; DSSTox_RID_77005; 17alpha-hydroxy-19-norpregn-4-en-20-yn-3-one; DSSTox_GSID_23380; (17alpha)-17-hydroxy-19-norpregn-4-en-20-yn-3-one; (14beta,17alpha)-17-Ethynyl-17-Hydroxyestr-4-En-3-One; 19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-; Norethindrone [USAN]; Norethindirone; (17alpha)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one; Micronor (TN); (8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one; SMR000499579; Primolut-N (TN); Camila (TN); N.E.E.; Nor-Q.D; CAS-68-22-4; NCGC00094738-01; CPD000499579; ENT; NET; Prestwick_646; Norethisterone [INN]; Norethisterone (JP17); Prestwick0_000253; Prestwick1_000253; Prestwick2_000253; Prestwick3_000253; EC 200-681-6; N.E.E; SCHEMBL23390; BSPBio_000066; Levonorgestrel EP Impurity U; MLS001076679; MLS001163874; ARONIS24281; Norethisterone / norethindrone; SPBio_002285; BPBio1_000074; GTPL2880; 17-Ethynyl-19-Nortestosterone; DTXSID9023380; 17-Ethinyl-19-nor-testosterone; BBC/437; VIKNJXKGJWUCNN-XGXHKTLJSA-N; HMS1568D08; HMS2090D21; HMS2095D08; HMS2231E18; HMS3259C16; HMS3712D08; BCP28306; HY-B0554; 17alpha-pregn-4-en-20-yn-3-one; Tox21_111322; Tox21_302427; 19-Norethindrone, >=98%, powder; BDBM50148732; LMST02030097; MFCD00067596; s4040; ZINC85205451; AKOS005267172; Tox21_111322_1; CCG-220253; CS-2664; DB00717; MCULE-9156628994; NC00576; SC-4640; KS-000048I5; NCGC00179669-01; NCGC00179669-02; NCGC00179669-04; NCGC00255187-01; AC-11100; AS-56451; LS-97425; SC-16223; 17alpha-Ethynyl-17-hydroxyest-4-en-3-one; 17alpha-Ethynyl-3-oxo-4-estren-17beta-ol; N0449; 17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one; C05028; D00182; 17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one; 17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one; 067N596; 17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one; Q421352; SR-01000765382; 17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone; SR-01000765382-3; W-104686; 13-methyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one; 17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one; 17-Hydroxy-19-nor-17alpha-4-pregnen-20-yn-3-one; 17-hydroxy-19-nor-17alpha-pregn-4-en-20yn-3-one; 19-Nor-17alpha-ethynyl-4-androsten-17beta-ol-3-one; 19-Norethindrone, VETRANAL(TM), analytical standard; BRD-K92073408-001-03-3; BRD-K92073408-001-16-5; 17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one; 17-Ethynyl-17-hydroxyestr-4-en-3-one (ACD/Name 4.0); 17alpha-Ethynyl-17beta-hydroxy-19-nor-4-androsten-3-one; Norethisterone, British Pharmacopoeia (BP) Reference Standard; Norethisterone, European Pharmacopoeia (EP) Reference Standard; 19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy- (8CI); Norethindrone, United States Pharmacopeia (USP) Reference Standard; Norethisterone for system suitability, European Pharmacopoeia (EP) Reference Standard; Norethindrone (Norethisterone), Pharmaceutical Secondary Standard; Certified Reference Material; Norethisterone; 19-Norethisterone; 17?-Ethynyl-19-nortestosterone; 17-Hydroxy-19-nor-17?-pregn-4-en-20-yn-3-one; Norethindrone [USP]; 4-08-00-01221 (Beilstein Handbook Reference)
Norfloxacin 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid; Norfloxacin; 5-23-03-00135 (Beilstein Handbook Reference)
Novobiocin N-[7-[[3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-alpha-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-benzamide; Novobiocin; U 6391
O,O-Diethyl hydrogen thiophosphate Phosphorthioic acid O,O-diethyl ester; O,O-Diethyl phosphorothionate; DETP
O,O-Dimethyl phosphorothionate Phosphorothioic acid, O,O-Dimethyl ester; O,O-Dimethyl phosphorothionate; AI3-21247
Ochratoxin A (R)-N-[(5-Chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine; Ochratoxin A; 5-18-09-00056 (Beilstein Handbook Reference)
Octanoic acid Caprylic acid; C-8 acid
Octhilinone 2-Octyl-3(2H)-isothiazolone; Octhilinone; 26530-20-1; 2-octylisothiazol-3(2H)-one; 2-n-Octyl-4-isothiazolin-3-one; 2-Octyl-4-isothiazolin-3-one; 2-Octyl-3-isothiazolone; Pancil; 2-Octyl-2H-isothiazol-3-one; 2-Octyl-3(2H)-isothiazolone; 3(2H)-Isothiazolone, 2-octyl-; Kathon 893; Skane 8; Skane M-8; Kathon 893F; Micro-chek skane; Kathon LM; Microbicide M-8; Micro-chek 11; Micro-chek 11D; Kathon SP 70; Kathon LP preservative; Kathon 4200; Pancil-T; Skane M8; 2-octyl-1,2-thiazol-3-one; Caswell No. 613C; 4-Isothiazolin-3-one, 2-octyl-; UNII-4LFS24GD0V; Vinylzene IT 3000DIDP; Octyl-3(2H)-isothiazolone; RH 893; Octhilinone [ANSI:BSI:ISO]; CCRIS 6082; EINECS 247-761-7; 2-Octyl-3-isothioazolone; 2-Octyl-3-isothiazolinone; Octyl-4-isothiazol-3-one; EPA Pesticide Chemical Code 099901; 2-n-Octyl-3-isothiazolone; BRN 1211137; 4LFS24GD0V; MLS002415697; CHEBI:81936; JPMIIZHYYWMHDT-UHFFFAOYSA-N; 2-octyl-1,2-thiazol-3(2H)-one; SMR001370885; DSSTox_CID_5805; DSSTox_RID_77928; DSSTox_GSID_25805; W-107168; Kathon; CAS-26530-20-1; C11H19NOS; Pancil T; Skane M 8; ACMC-1CDE4; Vinyzene IT 3000DIDP; SCHEMBL15648; cid_33528; KSC163A4D; SCHEMBL396433; CHEMBL1562104; DTXSID1025805; BDBM66023; KS-00000ZYZ; ZINC2012904; Tox21_201459; Tox21_300566; ANW-26014; RH-893; AKOS015897428; LS-1106; RTR-012025; TRA0009500; ACM25339531; ACM26530201; NCGC00091875-01; NCGC00091875-02; NCGC00091875-03; NCGC00091875-04; NCGC00091875-05; NCGC00254466-01; NCGC00259010-01; AK109069; AS-11894; CC-11727; Octhilinone 10 microg/mL in Acetonitrile; AX8013468; DB-028182; TR-012025; FT-0613248; O0343; O0378; ST24028121; C18752; K-6861; 530O201; C-24530; Q2013949; 2-Octyl-4-isothiazolin-3-one, PESTANAL(R), analytical standard; Octhilinone; BRN 1211137
Ofloxacin 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Ofloxacin; DL-8280
Okadaic acid (alphaR,2S,5R,6R,8S)-alpha,5-dihydroxy-alpha,10-dimethyl-8-[(1R,2E)-1-methyl-3-[(2R,4'aR,5R,6'S,8'R,8'aS)-octahydro-8'-hydroxy-6'-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl]butyl]-7'-methylenespiro[furan-2(3H),2'(3'H)-pyrano[3,2-b]pyran]-5-yl]-2-propen-1-yl]-1,7-Dioxaspiro[5.5]undec-10-ene-2-propanoic acid; Okadaic acid; CCRIS 3329
Omeprazole 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; omeprazole; 73590-58-6; Losec; Prilosec; Antra; Esomeprazole; Omeprazon; Audazol; Omapren; Omepral; Parizac; Zegerid; Mopral; Miol; Belmazol; Ceprandal; Dizprazol; Dudencer; Emeproton; Epirazole; Gastrimut; Gastroloc; Gibancer; Indurgan; Inhibitron; Inhipump; Logastric; Pepticum; Peptilcer; Prazidec; Sanamidol; SecrepiUlcometion; Mepral; Miracid; Omeprol; Omezol; Omisec; Omizac; Ompanyt; Ozoken; Prysma; Ramezol; Ulceral; Ulcesep; Ulcozol; Zefxon; Zoltum; Desec; Elgam; Lomac; Ulsen; Ultop; Zimor; Ocid; Omed; Omid; OMEP; Demeprazol; Nopramin; Omezolan; Paprazol; Pepticus; Prazentol; Prazolit; Procelac; Regulacid; Danlox; Erbolin; Lensor; Morecon; Nilsec; Olexin; Omegast; Omesek; Ortanol; Osiren; Proclor; Result; Ulcsep; Victrix; Zepral; Exter; Gasec; Ulzol; Omebeta 20; Tedec Ulceral; AULCER; Antra MUPS; Omerprazole; Omeprazol; Omez; Prilosec OTC; Omepradex; Omeprazolum; Nexium IV; H 168/68; Omeprazol [INN-Spanish]; Omeprazolum [INN-Latin]; Gastrogard; Nuclosi( -)-Omeprazole; Omesec; 119141-88-7; Esomperazole; Prestwick_808; CCRIS 7099; OMZ; CHEBI:77260; HSDB 3575; Esomeprazole sodium salt; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole; MFCD00083192; Nexium; H-168/68; CHEMBL1503; Nexiam; r-omeprazole; 1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-; 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; MLS000069373; C17H19N3O3S; SUBDBMMJDZJVOS-UHFFFAOYSA-N; (S)-Esomeprazole; Aisi'aomeilazuona Esomeprazole Sodium; 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole; 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; Omeprazole, 98+%; NCGC00016925-06; SMR000058847; Emilok; CAS-73590-58-6; DSSTox_CID_1080; (s)-omeprazole sodium; 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole; DSSTox_RID_75929; DSSTox_GSID_21080; Omeprazone; Omeprazen; Omeprazole delayed-release; Omeprazole Pellets; 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole; 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole; Prilosec (TN); (+-)-Omeprazole; Omeprazole [USAN:INN:BAN:JAN]; SR-01000003003; 161796-78-7; Omperazole; Omeprazole, solid; 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; AGI-010; Omeprazole,(S); H 168-68; 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; DM-3458; Omeprazole [USAN:USP:INN:BAN:JAN]; Omeprazole (Prilosec); ACMC-20p1du; Maybridge4_002645; Opera_ID_1863; Prestwick0_000493; Prestwick1_000493; Prestwick2_000493; Prestwick3_000493; (.+/-.)-Omeprazole; O0359; UPCMLD-DP075; 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; cid_4594; SCHEMBL1191; BSPBio_000385; MLS001076112; MLS001424148; MLS006010400; MLS006011759; BIDD:GT0189; SPBio_002306; BPBio1_000425; GTPL4279; Omeprazole (JP17/USP/INN); Esomeprazole sodium salt hydrate; DTXSID6021080; SCHEMBL11995456; UPCMLD-DP075:001; CHEBI:91766; CTK8I2124; CTK9A5793; HMS1528I05; HMS1569D07; HMS2052G17; HMS2090E16; HMS2090F11; HMS2096D07; HMS2232B21; HMS3269D17; HMS3394G17; HMS3413J07; HMS3651A11; HMS3677J07; HMS3713D07; Pharmakon1600-01505693; (S)-Omeprazole sodium salt hydrate; BCP05852; BCP13592; BCP21299; HY-B0113; KS-000001KH; 2,3,5-Trimethylpyridine/Omeprazole; Tox21_110686; Tox21_200509; AC-401; BBL028172; BDBM50103597; BDBM50241343; CO0037; DL-462; NSC751450; NSC759192; s1389; STK623746; 119141-88-7 (base); AKOS005066653; AKOS015895343; Tox21_110686_1; AC-4676; CCG-101130; CCG-213517; CS-1868; DB00338; HS-0055; LS-7629; MCULE-3224208952; NC00380; NE55490; NSC-751450; NSC-759192; IDI1_032523; NCGC00016925-01; NCGC00016925-02; NCGC00016925-03; NCGC00016925-04; NCGC00016925-05; NCGC00016925-07; NCGC00016925-08; NCGC00016925-10; NCGC00016925-11; NCGC00021522-03; NCGC00021522-04; NCGC00021522-05; NCGC00258063-01; Omeprazole, analytical reference material; AK162396; CPD000058847; K253; SAM001246900; SC-15162; SY077145; SBI-0206896.P001; AB0014122; AB1009257; FT-0601585; FT-0652860; FT-0653294; H 199; ST24048844; SW196942-4; A19447; C07324; D00455; J10125; 668985-31-7 (Mg); 141O887; A837865; H168/68; Q422210; SR-01000003003-4; SR-01000003003-7; SR-01000003003-8; 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl); BRD-A55962179-001-04-9; BRD-A55962179-001-08-0; BRD-A55962179-001-20-5; BRD-A88691025-001-07-4; F0001-2386; Z1672902589; Omeprazole, British Pharmacopoeia (BP) Reference Standard; Omeprazole, European Pharmacopoeia (EP) Reference Standard; Omeprazole, United States Pharmacopeia (USP) Reference Standard; 2-(3-methoxy-2,4-dimethylbenzylsulfinyl)-6-methoxy-1H-benzo[d]imidazole; 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-; Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material; (+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole; (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole; (RS)-5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridylmethylsulphinyl)benzimidazole; 1H-Benzimidazole,5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-; 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyrdinyl)-methyl]sulfinyl]-1H-benzimidazole; 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole; 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole; 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; 5-methoxy-2-(2-(4-methoxy-3,5-dimethylpyridin-2-yl)ethylsulfinyl)-1H-benzo[d]imidazole; 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole; 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole; 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole; 5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole; 5-methoxy-2-[[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole; 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole; 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-benzimidazole; 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]1H-benzimidazole; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole; 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole; 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole; 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole; 6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole; 6-methoxy-2-[[(4-methoxy3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole; 6-methoxy-2-[[(4methoxy-3,5-dimethyl2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole; Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard; Omeprazole solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; (omeprazole)5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole; (RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole; 131959-78-9; 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole (omeprazole); 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole(Omeprazole); 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Antra; Losec; 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt; Omeprazole; H 168/68
Onapristone (11beta,13alpha,17alpha)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)estra-4,9-dien-3-one; Onapristone; CCRIS 6530
Ormetoprim 5-[(4,5-Dimethoxy-2-methyl)phenylmethyl]-2,4-pyrimidine; Ormetoprim; component of Rofenaid
Ornidazole alpha-(Chloromethyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol; Ornidazole; 16773-42-5; Tiberal; Ornidazolum; Madelen; Ro 7-0207; Ornidazol; 1-chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol; 1-(3-Chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole; NSC 95075; 1-(2-Hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole; Ornidazole [USAN:INN]; Ornidazol [INN-Spanish]; Ornidazolum [INN-Latin]; 1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol; Ornidazole Levo-; Ro-70207; CCRIS 9030; CHEBI:75176; EINECS 240-826-0; BRN 0614299; C7H10ClN3O3; MLS000028628; alpha-(Chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol; alpha-(Chloromethyl)-2-methyl-5-nitroimidazole-1-ethanol; alpha-(Chloromethyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol; 1H-Imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro-; NSC95075; NSC-95075; 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol; .alpha.-(Chloromethyl)-2-methyl-5-nitroimidazole-1-ethanol; AK-60553; SMR000058726; Imidazole-1-ethanol, .alpha.-(chloromethyl)-2-methyl-5-nitro-; 1H-Imidazole-1-ethanol, .alpha.-(chloromethyl)-2-methyl-5-nitro-; alpha-(Chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol [German]; DSSTox_CID_25420; DSSTox_RID_80868; DSSTox_GSID_45420; Q-201520; 1-chloro-3-(2-methyl-5-nitro-1-imidazolyl)-2-propanol; Imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro-; Ornidal; SR-01000000256; Ro7-0207; 3-chloro-1-(2-methyl-5-nitroimidazolyl)propan-2-ol; Ornidazole,(S); NCGC00016723-01; Prestwick_584; CAS-16773-42-5; Opera_ID_1555; Ornidazole (USAN/INN); Prestwick0_000164; Prestwick1_000164; Prestwick2_000164; Prestwick3_000164; (.+/-.)-Ornidazole; NCIOpen2_006374; SCHEMBL43039; BSPBio_000027; 5-23-05-00072 (Beilstein Handbook Reference); MLS001424188; ARONIS23874; SPBio_001948; Ornidazole, analytical standard; BPBio1_000031; CHEMBL1449676; DTXSID4045420; CTK8B7883; 1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitro-imidazole; 1-chloro-3-(2-methyl-5-nitro-imidazol-1-yl)propan-2-ol; BBC/159; IPWKIXLWTCNBKN-UHFFFAOYSA-N; HMS1568B09; HMS2051D22; HMS2093J22; HMS2095B09; HMS2234L22; HMS3373M17; HMS3393D22; HMS3652C03; HMS3712B09; Pharmakon1600-01505981; BB_SC-04838; BCP12975; BCP13382; HY-B0508; KS-00000XM2; KS-000046IF; ZX-AS004376; Tox21_110582; ANW-58859; BBL005302; BDBM50247904; HTS028365; MFCD00057960; NSC759295; s3121; SBB006918; STK629340; AKOS005111039; AKOS015894928; Tox21_110582_1; AB02333; AC-2025; AM86682; API0003694; CCG-101064; CCG-213587; CS-2710; DB13026; MCULE-7000574302; NC00314; NSC-759295; NCGC00018275-02; NCGC00018275-05; AS-12121; CC-33355; CPD000058726; LS-78598; SAM001246873; SC-77073; SBI-0206881.P001; AB0011335; AB1004855; AX8146303; BB0293349; RO-7-0207; TR-007269; AB00513814; FT-0630433; O0417; ST24027072; ST45053251; SW196758-4; D05274; K-5196; AB00383044_14; AB00383044_15; 773O425; A810899; Q2358146; SR-01000000256-3; SR-01000000256-4; BRD-A42759514-001-03-1; BRD-A42759514-001-09-8; Ornidazole,1(3-chloro-2-hydroxypropyl)-2-methyl-5-; .alpha.-(Chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol; 1-chloranyl-3-(2-methyl-5-nitro-imidazol-1-yl)propan-2-ol; 1-chloro-3-(2-methyl-5-nitro-1N-imidazol-1-yl)propan-2-ol; .alpha.-(Chloromethyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol; 1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol #; alpha-(Chloromethyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol (9CI); Ornidazole; 5-23-05-00072 (Beilstein Handbook Reference)
Ornithine L-Ornithine; L-ornithine; ornithine; 70-26-8; (S)-2,5-Diaminopentanoic acid; (S)-Ornithine; Ornithine [INN]; L-Norvaline, 5-amino-; (S)-alpha,delta-Diaminovaleric acid; Ornithinum [Latin]; Ornitina [Spanish]; polyornithine; (2S)-2,5-diaminopentanoic acid; (S)-2,5-diaminovaleric acid; Poly-L-ornithine; Ornithine (VAN); L( )-Ornithine; (S)-2,5-Diaminopentanoate; L-Ornithine, homopolymer; Pentanoic acid, 2,5-diamino-, (S)-; ORNITHINE, L-; UNII-E524N2IXA3; (+)-S-Ornithine; BRN 1722298; L-(-)-Ornithine; C5H12N2O2; EINECS 200-731-7; E524N2IXA3; CHEBI:15729; Ornithine (INN); W-104562; Ornithinum; Ornitina; L(-)-Ornithine; levo-ornithine; 1hqg; 1lah; 3jdw; ORN; [3H]-L-Ornithine; 5-amino-L-Norvaline; L-Ornithine (9CI); 5-diaminopentanoic acid; (S)-a,d-Diaminovalerate; Ornithine, L- (8CI); bmse000162; SCHEMBL8579; GTPL725; (S)-a,d-Diaminovaleric acid; 4-04-00-02644 (Beilstein Handbook Reference); KSC353M1P; Pentanoic acid, 2,5-diamino; CHEMBL446143; alpha, delta-diaminovaleric acid; CTK2F3617; DTXSID00883219; AHLPHDHHMVZTML-BYPYZUCNSA-N; L-Ornithine2,5-Diaminovalericacid; Pharmakon1600-01504524; HY-B1352; ZINC1532530; (R,S)-2,5-Diamino-pentanoic acid; FCH919863; NSC758894; AKOS006239312; CS-4817; DB00129; MCULE-3029872280; NE11434; NSC-758894; SMP2_000009; NCGC00263569-01; 25104-12-5; AC-13803; CC-30033; LS-98388; O422; SC-18299; AX8136676; LS-185995; RT-000211; (S)-2; FT-0082310; FT-0627977; S4653; EN300-96942; C00077; D08302; 070O268; C-34264; Q410198; UNII-2381769MQC component AHLPHDHHMVZTML-BYPYZUCNSA-N; 8AB10027-4D34-488A-9F55-E86692CA2853; 3485-66-3; Ornithine; 4-04-00-02644 (Beilstein Handbook Reference)
Orotic acid Acide orotique [French]
Orthosomycins Avilamycin
Other medicines unspecified (AI)
Ouabain ouabain; G-Strophanthin; Ouabaine; Ouabagenin L-rhamnoside; Oubain; Ouabain anhydrous; Acocantherin; Astrobain; Gratibain; Purostrophan; Ouabain octahydrate; 630-60-4; Acocantherine; Ouabagenin-L-rhamnosid; Strophalen; Kombetin; Strodival; UabaiUabanin; Gratus strophanthin; RectobaiSolufantiStrophoperm; Strophosan; G-Strophicor; Quabain; UNII-5ACL011P69; CHEBI:472805; MLS000069786; CHEMBL222863; LPMXVESGRSUGHW-HBYQJFLCSA-N; Ouabain, Octahydrate; 5ACL011P69; Ouabagenin-L-rhamnosid [German]; SMR000058492; Strophanthin-G; DSSTox_CID_23765; DSSTox_RID_80072; DSSTox_GSID_43765; 3-(alpha-L-rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide; Card-20(22)-enolide, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-, (1.beta.,3.beta.,5.beta.,11.alpha.)-; CCRIS 965; OBN; HSDB 3519; EINECS 211-139-3; NSC 25485; NSC-25485; BRN 0101712; 4-[(1S,2R,3R,5S,7S,10R,11S,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxymethyl)-15-methyl-5-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one; CAS-630-60-4; G-Strophanthin (JAN); SR-01000076047; Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11,14,19-pentahydroxy-, (1beta,3beta,5beta,11alpha)-; 11018-89-6; Cardiac glycoside; 1ibg; 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11alpha,14,19-pentahydroxycard-20(22)-enolide; 3-(6-Deoxy-alpha-L-mannopyranosyloxy)-1,5,11a,14,19-pentahydroxycard-20(22)-enolide; NCGC00163473-01; 3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; 3a3y; Opera_ID_395; 4-[5-((6S,2R,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4,5,6-tetrahydropyran-2- yloxy))(1S,5S,7S,11S,2R,3R,10R,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxym ethyl)-15-methyltetracyclo[8.7.0.0<2,7>.0<; Prestwick0_000471; Prestwick1_000471; Prestwick2_000471; Prestwick3_000471; Epitope ID:161502; O 3125; Lopac0_000943; SCHEMBL15433; BSPBio_000602; 5-18-05-00625 (Beilstein Handbook Reference); SPBio_002541; BPBio1_000664; cid_439501; GTPL4826; DTXSID0043765; REGID_for_CID_439501; 3n23; HMS2089J19; HMS2235A07; HMS3262N08; ZINC8143614; Tox21_110024; Tox21_112057; Tox21_301547; Tox21_500943; BDBM50286739; AKOS024285581; Tox21_112057_1; CCG-205024; CCG-208243; DB01092; LP00943; SDCCGSBI-0050917.P002; SMP1_000142; NCGC00013319-01; NCGC00017394-02; NCGC00017394-07; NCGC00017394-11; NCGC00255970-01; NCGC00261628-01; NCGC00263656-01; ST085767; EU-0100943; C01443; D00112; 11,15>]heptadec-14-yl]-5-hydrofuran- 2-one; Q285911; SR-01000721848; SR-01000076047-1; SR-01000076047-5; SR-01000721848-2; SR-01000721848-4; BRD-K35708212-331-03-1; (1alpha,3beta,5beta,11alpha,17alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; (1beta,3beta,5beta,11alpha)-3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-1,5,11.alpha.,14,19-pentahydroxycard-20(22)-enolide; 4-((1R,3S,5S,8R,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-((1R,3S,5S,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 4-[(1R,3S,5S,10R,11R,13R,14S,17R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[(R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one(Ouabain); Ouabain4-[1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 5-18-05-00625 (Beilstein Handbook Reference)
Oxamic acid 2-Amino-2-oxo-acetic acid; Oxamic acid; AI3-52243
Oxazepam 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; oxazepam; Tazepam; Serax; Adumbran; 604-75-1; Droxacepam; Ansioxacepam; Anxiolit; Durazepam; Nesontil; Noctazepam; Praxiten; Psiquiwas; Quilibrex; Aplakil; Astress; Bonare; Drimuel; Isodin; Limbial; Murelax; Pacienx; Propax; Rondar; Sedigoa; Serenal; Serenid; Serepax; Seresta; Serpax; Sobril; Zaxopam; Vaben; Hi-Long; Azutranquil; Nortemazepam; Psicopax; Sigacalm; Uskan; (RS)-Oxazepam; Nozepam; Tarchomin; (+-)-Oxazepam; Serenid-D; Abboxapam; Lederpam; Oxazepamum; Oxozepam; Alepam; Oxanid; Tacepam; Anxiolit retard; QUEN; Tranquo-buscopan-wirkstoff; Oxa-puren; Z10-Tr; WY-3498; N-Desmethyltemazepam; Ossazepam [DCIT]; Oxazepamum [INN-Latin]; 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-; Ro 5-6789; CB 8092; Z 10 tr; Wy 3498; 7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; CCRIS 488; 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one; HSDB 3140; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; EINECS 210-076-9; NSC 169448; CHEBI:7823; DEA No. 2835; ADIMAYPTOBDMTL-UHFFFAOYSA-N; 1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; NSC-169448; NCGC00159323-02; NCGC00159323-03; Ossazepam; Oxazipam; DSSTox_CID_1087; (+-)-7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; DSSTox_RID_75934; DSSTox_GSID_21087; Abboxampam; Azutranguil; Hilong; Apo-astress; p acienx; 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-, (+-)-; CAS-604-75-1; Serax (TN); Oxazepam [USAN:INN:BAN:JAN]; Oxazepam (JAN/USP/INN); Oxazepam civ; 3-Hydroxynordiazepam; Oxazepam [USAN:USP:INN:BAN:JAN]; (.+/-.)-Oxazepam; CHEMBL568; tranquo-buscopan- wirkstoff; Oprea1_501459; SCHEMBL27435; Temazepam impurity, oxazepam-; DivK1c_000986; GTPL7253; DTXSID1021087; NIOSH/DF2371850; ADIMAYPTOBDMTL-UHFFFAOYSA-; BDBM85031; HMS503E13; KBio1_000986; Oxazepam 0.1 mg/ml in Methanol; Oxazepam 1.0 mg/ml in Methanol; NINDS_000986; LS-44; NSC_4616; Tox21_111572; Tox21_112819; Tox21_200700; Tox21_303501; 1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one; 7-Chloro-1,4-benzodiazepine-2-one; MFCD00057903; NSC169448; AKOS016347293; API0003709; DB00842; J3.308A; IDI1_000986; WLN: T67 GMV JN IHJ CG IQ KR; NCGC00159323-04; NCGC00257352-01; NCGC00258254-01; CAS_604-75-1; LS-34236; DF23718500; FT-0673333; C07359; D00464; 604O751; Q412299; SR-01000942251; 2H-1, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-; 7-chloro-5-phenyl-3H-1,4-benzodiazepine-2,3-diol; SR-01000942251-1; 7-Chloro-3-hydroxy-5-phenyl-1,4-benzodiazepin-2-one; Oxazepam solution, drug standard, 1.0 mg/mL in methanol; Oxazepam, European Pharmacopoeia (EP) Reference Standard; (Z)-7-chloro-3-hydroxy-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one; 3-hydroxy-1,3-dihydro-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one; 3-hydroxy-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one; 3H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-3-hydroxy-5-phenyl-; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-1,4 [2H]-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-1,4 [2Hl-benzodiazepin-2-one; 7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one; 7-chloro-3-hydroxy-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; 7-CHLORO-3-HYDROXY-5-PHENYL-1,3-DIHYDRO-2H-BENZO[E][1,4]DIAZEPIN-2-ONE; Oxazepam for peak identification, European Pharmacopoeia (EP) Reference Standard; Oxazepam solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material; InChI=1/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19); Oxazepam; Z 10 tr
Oxazolidinones Cadazolid; Linezolid; Radezolid; Tedizolid
Oxibendazole (5-Propoxy-1H-benzimidazol-2-yl)carbamic acid, Methyl ester; Oxibendazole; 2-Benzimidazolecarbamic acid, 5-propoxy-, methyl ester
Oxolinic acid 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; Oxolinic acid; S-0208